数据链接：
官方服务：
资源简介：
The IC50 value of the first generation PARP inhibitor, 3-AB, is measured for reference.
应用场景：
创建时间：
2015-12-02
相关数据集
The effect of PARP inhibitors in homologous recombination proficient ovarian cancer: meta-analysis
BRCA1/2 mutations and homologous recombination deficiency (HRD) predispose to increased sensitivity to poly(ADP-ribose)polymerase (PARP) inhibitor treatment. Our aim was to evaluate the PARP inhibitor
Figshare2022-05-13 更新60
Additional file 2: of The BRCA1ness signature is associated significantly with response to PARP inhibitor treatment versus control in the I-SPY 2 randomized neoadjuvant setting
I-SPY 2 Trial participating sites and institutional review boards (IRB). (XLSX 48 kb)
NIAID Data Ecosystem40
Infinium MethylationEPIC BeadChip array data for HGSOC PH039 PDXs at baseline and treated with cycles of 100 mg/kg niraparib for 21 days for four treatment rounds and murine sample.. Infinium MethylationEPIC BeadChip array data for HGSOC PH039 PDXs at baseline and treated with cycles of 100 mg/kg niraparib for 21 days for four treatment rounds and murine sample.
Infinium MethylationEPIC BeadChip array data for HGSOC PH039 PDXs at baseline and treated with cycles of 100 mg/kg niraparib for 21 days for four treatment rounds and murine sample. Overall design: In
NIAID Data Ecosystem10
Supplementary Material for: Case Report of Complete Response to Olaparib in a Patient with Breast Cancer Brain Metastases
Introduction: Breast cancer is the second most common cause of central nervous system (CNS) metastases. It has been shown that the median time from breast cancer diagnosis to CNS metastasis is 30.9 mo
NIAID Data Ecosystem60
Visual Characterization and Diversity Quantification of Chemical Libraries: 1. Creation of Delimited Reference Chemical Subspaces
High-throughput screening (HTS) is a well-established technology which can test up to several million compounds in a few weeks. Despite these appealing capabilities, available resources and high costs
NIAID Data Ecosystem30
